Geoffrey Ling M.D.
CIK: 0001800097
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CELU
Celularity Inc
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 12, 2026CELU
Celularity Inc
Award(A)Direct19.2K shares- - Dec 29, 2025CELU
Celularity Inc
Award(A)Direct125K shares- - Dec 19, 2025CELU
Celularity Inc
Award(A)Direct67.4K shares- - Nov 19, 2025CELU
Celularity Inc
Award(A)Direct44.4K shares- - Dec 19, 2024CELU
Celularity Inc
Award(A)Direct67.4K shares-
1-5 of 5 transactions
About Ling Geoffrey M.D.
Ling Geoffrey M.D. (SEC CIK 0001800097) files insider reports with the SEC as Director of Celularity Inc (CELU).
Signal8 holds 6 ownership filings by Ling Geoffrey M.D., all Form 4s, filed between Jan 6, 2025 and Jan 15, 2026. Those filings report 5 transactions, from Dec 19, 2024 to Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ling Geoffrey M.D.'s filings is in FLORHAM PARK, NJ.
Recent filings by Ling Geoffrey M.D.
- Jan 12, 2026: Grant or award of CELU shares (Form 4, code A).
- Dec 29, 2025: Grant or award of CELU shares (Form 4, code A).
- Dec 19, 2025: Grant or award of CELU shares (Form 4, code A).
- Nov 19, 2025: Grant or award of CELU shares (Form 4, code A).
- Dec 19, 2024: Grant or award of CELU shares (Form 4, code A).
Other insiders filing for Celularity Inc (CELU)
- Philip & Daniele Barach Family Trust, 10% Owner
- Barach Daniele Wolf, 10% Owner
- Barach Philip Alan, Director
- Brigido Stephen, Pres., Functional Regeneration
- Haines John R, Senior Exec Vice President
- Hariri Robert J, Chief Executive Officer